Abstract
The particular surgical interest with regard to focal lesions of the liver is directed towards three main areas which will be discussed subsequently in this article: diagnostic tools, differential diagnosis and indication for surgery; surgical therapy and modalities; patient survival and prognosis. First of all, there are two crucial questions to be asked by the surgeon (Figure 6.1):
-
1.
Is there any indication at all for surgery? The answer clearly depends on the aetiology and character of the lesion. As a principle, tumours can be differentiated into benign or malignant types. Fairly common and well-known benign solid tumours are cavernous haemangioma, focal nodular hyperplasia (FNH), and hepatocellular adenoma. While, in haemangioma and FNH, spontaneous rupture and intraperitoneal bleeding are extremely rare, and also malignant transformation is still in discussion in only very few cases of FNH, these particular complications have been reported to occur in adenoma1–6. Therefore, it is our own strategy in patients with the clearly established diagnosis of haemangioma or FNH to recommend surgical resection only in cases of symptomatic disease and/or tumour growth. In contrast, due to the risks as described above, surgery for cure should always be performed not only in suspected but also in clearly diagnosed cases of adenoma 2, 4–10. The question of indication for treatment is somewhat easier in primary or malignant hepatic tumours. Since the spontaneous prognosis is usually fatal within a limited period of time, and currently no alternative effective therapy is available, radical surgery with the aim of potentially curative tumour removal is undoubtedly the treatment of first choice whenever possible.
-
2.
Is the hepatic lesion resectable? In order to answer this very important question before operation most precisely, all information available about the anatomy of the lesion must be taken together: exact localization, size and number of the tumours within and outside the liver, as well as involvement of vascular or biliary structures, regional lymph nodes, neighbouring and distant other organs. These data are a prerequisite, not only to decide about the surgical resectability, but also to have an accurate tumour classification and staging which has significant implications for the overall prognosis, especially of patients with malignancies. There are different staging systems in use for primary and also secondary malignant tumours of the hepatobiliary system. At present, most suitable for clinical application seems to be the TNM classification of the International Union against Cancer11. Of course, apart from anatomic resectability, the functional capacity of the liver (e.g. in cirrhosis) and the patient’s clinical condition must be taken into consideration before surgery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Hobbs KEF. Hepatic hemangiomas. World J Surg. 1980; 14:468–71.
Iwatsuki S, Todo S, Starzl TE. Excisional therapy for benign hepatic lesions. Surg Gynecol Obstet. 1990; 171: 240–6.
Kerlin P, Davis GL, McGill DB, Weiland LH, Adson MA, Sheedy PF. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic and radiologic features. Gastroenterology. 1983;84:994–1002.
Leese T, Farges O, Bismuth H. Liver cell adenomas A 12-year experience from a specialist hepato-biliary unit. Ann Surg. 1988;208:558–64.
Nichols FC, van Heerden JA, Weiland LH. Benign liver tumors. Surg Clin N Am. 1988;69:297–314.
Trastek VF, van Heerden JA, Sheedy II PF, Adson MA. Cavernous hemangiomas of the liver: Resect or observe? Am J Surg. 1983;145:49–53.
Foster JH. Benign liver tumors. World J Surg. 1982; 6:25–31.
Lise M, Feltrin G, Da Pian PP, Miotto D, Pilatti PL, Rubaltelli L, Zane D. Giant cavernous hemangiomas: diagnosis and surgical strategies. World J Surg. 1992;16:516–20.
Ringe B, Mauz S, Barg-Hock H, Kotzerke J, Pichlmayr R. Chirurgie bei beningnen Lebertumoren. Langenbecks Arch Chir Suppl II. 1989;(Kongreßbericht 1989):287–91.
Weil III, Koep LJ, Starzl TE, Liver resection for hepatic adenoma. Arch Surg. 1979;114:178–80.
Hermanek P, Sobin LH, eds. TNM classification of malignant tumors. 4th fully revised ed. Berlin: Springer; 1987:56–9.
Gratz KF, Creutzig H, Brölsch C, Neuhaus P, Majewski A, Pichlmayr R, Hundeshagen H. Choleszintigraphie zum Nachweis der focal-nodulären Hyperplasie (FNH) der Leber? Chirurg. 1984;55:448–51.
Kotzerke J, Schwarzrock R, Krischek, Wiese H, Hundeshagen H. Technetium 99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma, adenoma and focal nodular hyperplasia. J. Nucl Med. 1989;30:1278–9.
Kudo M, Ikekubo K, Yamamoto K, Ibuki Y, Hino M, Tomita S, Komon H, Orino A, Todo A. Distinction between haemangioma of the liver and hepatocellular carcinoma: value of labeled RBC-SPECT scanning. Am J Roentgenol. 1989; 152:977–83.
Müller-Leisse C, Kujat Ch, Klose K, Büchsel R. Diagnostik der Fokal nodulären Hyperplasie. Röntgenpraxis. 1990;43:281–7.
Ros PR, Li KCP. Part II: Benign liver tumors. Curr Probl Diagn Radiol. 1989;May/June: 125–55.
Sandler MA, Petrocelli RD, Marks S, Lopez R. Ultrasonic features and radionuclide correlation in liver cell adenoma and focal nodular hyperplasia. Radiology. 1980;135:393–7.
Welch TJ, Sheedy PF, Johnson CM, Stephens DH, Charboneau JW, Brown ML, Ray GR, Adson MA, McGill DB. Focal nodular hyperplasia and hepatic adenoma: comparison of angiography, CT, US and scintigraphy. Radiology. 1985;156:593–5.
Weimann A, Barg-Hock H, Klempnauer J, Gratz KF, Grote R, Kotzerke J, Lang H, Wagner S, Ringe B, Pichlmayr R. Wertigkeit der Sonographie bei der Diagnostik und Verlaufskontrolle von Hämangiom und Fokal Nodulärer Hyperplasie der Leber. Ultraschall Klin Prax. 1994;[in press].
Gozzetti G, Mazziotti A, Grazi GL, Jovine E, Gallucci A, Morganti M, Frena A, Agucro V, Cavallari A. Surgical experience with 168 primary liver cell carcinomas treated by hepatic resection. J. Surg Oncol (Suppl). 1993;3:59–61.
Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, Tzakis AG, Van Thiel DH, Carr B, Selby R, Madariaga J. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg. 1991;214:221–9.
Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients. World J Surg. 1991;15:270–85.
Bismuth H, Chicle L, Adam R, Castaing G. Surgical treatment of hepatocellular carcinoma in cirrhosis: Liver resection or transplantation? Transplant Proc. 1993;25:1066–7.
Couinaud C. Surgical anatomy of the liver revisited. Paris: Depot legal:2ieme trimestre: 1989.
Fortner JG, Shiu MH, Kinne DW, Castro EB, Watson RC, Howland WS, Beattie EJ. Major hepatic reactions using vascular isolation and hypothermic perfusion. Ann Surg. 1974;180:644–52.
Pichlmayr R, Grosse H, Hauss J, Gubernatis G, Lamesh P, Bretschneider HJ. Technique and preliminary results of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liver. Br J Surg. 1990; 77:21–6.
Starzl TE, Todo S, Tzakis A, Podesta L, Mieles L, Demetris A, Teperman L, Selby R, Stevenson W, Stieber A, Gordon R, Iwatsuki S. Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg. 1989; 210:374–85.
Galanski M, Schmoll E, Reichelt S, Böhmer G, Prokop M, Schaefer C, Schüler A, Ringe B, Schmidt FW, Schmoll HJ. Chemoembolisation hepatozellulärer Karzinome bei isoliertem Leberbefall. Radiologe. 1992;32:49–55.
Tang ZY, Yu YQ, Zhou XD, Yang BH, Ma ZC, Lin ZY. Subclinical hepatocellular carcinoma: An analysis of 391 patients. J Surg Oncol (Suppl). 1993;3:55–8.
Ringe B, Bechstein WO, Raab R, Meyer HJ, Pichlmayr R. Leberresektion bei 157 Patienten mit colorektalen Metastasen. Chirurg. 1990;61:272–9.
Scheele J, Stang R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery. 1992;110:13–29.
O’Grady JG, Poison RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg. 1988;207:373–9.
Ringe B, Wittekind C, Bechstein WO, Bunzendahl H, Pichlmayr R. The role of liver transplantation in malignancy. A retrospective analysis with special regard to tumour stage and recurrence. Ann Surg. 1989;209:88–98.
Ismail T, Angrisani L, Gunson BK, Hübscher SG, Buckels JAC, Neuberger JM, Elias E, McMaster P. Primary hepatic malignancy: The role of liver transplantation. Br J Surg. 1990;77:983–7.
Olthoff K, Millis M, Rososve MH, Goldstein LI, Ramming KP, Busuttil RW. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg. 1990;125:1261–8.
Haug CE, Jenkins RL, Rohrer RJ, Auchincloss H, Delmonico FL, Freeman RB, Lewis WD, Cosimi AB. Liver transplantation for primary hepatic cancer. Transplantation. 1992; 53:376–82.
Moreno-Gonzalez EM, Gomez R, Garcia I, Gonzalez-Pinto I, Loinaz C, Ibanez J, Bercedo J, Palomo JC, Palma F, Vorwald P, Riano D, Perez Cerda F, Davila P, Cisneros C, Maffettone V, Sciadini M. Liver transplantation in malignant hepatic neoplasms. Am J Surg. 1992;163:395–400.
Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzl TE. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer. 1991;68:2095–100.
Pichlmayr R, Weimann A, Ringe B. Indications for liver transplantation in hepatobiliary malignancy. Hepatology. 1994, [in press].
Pichlmayr R, Ringe B, Gubernatis G, Hauss J, Bunzendahl H. Transplantation einer Spenderleber auf zwei Empfänger (Splitting-Transplantation) — Eine neue Methode in der Weiterentwicklung der Lebersegmenttransplantation. Langenbecks Arch Chir. 1988;373:127–30.
Adson MA. Editorial comment. Am J Surg. 1987; 156:372.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Ringe, B., Weimann, A., Pichlmayr, R. (1995). Surgical Aspects in the Imaging of Focal Hepatic Lesions. In: Balzer, T., Hamm, B., Niendorf, HP. (eds) Contrast Agents in Liver Imaging. Series in Radiology, vol 25. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0477-7_6
Download citation
DOI: https://doi.org/10.1007/978-94-011-0477-7_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4213-0
Online ISBN: 978-94-011-0477-7
eBook Packages: Springer Book Archive